Your browser doesn't support javascript.
loading
Mutational signatures in esophageal squamous cell carcinoma from eight countries with varying incidence.
Moody, Sarah; Senkin, Sergey; Islam, S M Ashiqul; Wang, Jingwei; Nasrollahzadeh, Dariush; Cortez Cardoso Penha, Ricardo; Fitzgerald, Stephen; Bergstrom, Erik N; Atkins, Joshua; He, Yudou; Khandekar, Azhar; Smith-Byrne, Karl; Carreira, Christine; Gaborieau, Valerie; Latimer, Calli; Thomas, Emily; Abnizova, Irina; Bucciarelli, Pauline E; Jones, David; Teague, Jon W; Abedi-Ardekani, Behnoush; Serra, Stefano; Scoazec, Jean-Yves; Saffar, Hiva; Azmoudeh-Ardalan, Farid; Sotoudeh, Masoud; Nikmanesh, Arash; Poustchi, Hossein; Niavarani, Ahmadreza; Gharavi, Samad; Eden, Michael; Richman, Paul; Campos, Lia S; Fitzgerald, Rebecca C; Ribeiro, Luis Felipe; Soares-Lima, Sheila Coelho; Dzamalala, Charles; Mmbaga, Blandina Theophil; Shibata, Tatsuhiro; Menya, Diana; Goldstein, Alisa M; Hu, Nan; Malekzadeh, Reza; Fazel, Abdolreza; McCormack, Valerie; McKay, James; Perdomo, Sandra; Scelo, Ghislaine; Chanudet, Estelle; Humphreys, Laura.
Afiliação
  • Moody S; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
  • Senkin S; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Islam SMA; Moores Cancer Centre, UC San Diego Health, La Jolla, CA, USA.
  • Wang J; Department of Cellular and Molecular Medicine, University of California, La Jolla, CA, USA.
  • Nasrollahzadeh D; Department of Bioengineering, University of California, La Jolla, CA, USA.
  • Cortez Cardoso Penha R; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
  • Fitzgerald S; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Bergstrom EN; Digestive Oncology Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Shariati Hospital, Tehran, Iran.
  • Atkins J; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • He Y; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
  • Khandekar A; Moores Cancer Centre, UC San Diego Health, La Jolla, CA, USA.
  • Smith-Byrne K; Department of Cellular and Molecular Medicine, University of California, La Jolla, CA, USA.
  • Carreira C; Department of Bioengineering, University of California, La Jolla, CA, USA.
  • Gaborieau V; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Latimer C; Moores Cancer Centre, UC San Diego Health, La Jolla, CA, USA.
  • Thomas E; Department of Cellular and Molecular Medicine, University of California, La Jolla, CA, USA.
  • Abnizova I; Department of Bioengineering, University of California, La Jolla, CA, USA.
  • Bucciarelli PE; Moores Cancer Centre, UC San Diego Health, La Jolla, CA, USA.
  • Jones D; Department of Cellular and Molecular Medicine, University of California, La Jolla, CA, USA.
  • Teague JW; Department of Bioengineering, University of California, La Jolla, CA, USA.
  • Abedi-Ardekani B; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Serra S; Evidence Synthesis and Classification Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Scoazec JY; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Saffar H; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
  • Azmoudeh-Ardalan F; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
  • Sotoudeh M; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
  • Nikmanesh A; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
  • Poustchi H; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
  • Niavarani A; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
  • Gharavi S; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Eden M; University Health Network, Toronto, Ontario, Canada.
  • Richman P; Department Laboratory Medicine and Pathology, Gustave Roussy, Paris, France.
  • Campos LS; Department of Pathology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Fitzgerald RC; Liver Transplantation Research Center, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
  • Ribeiro LF; Digestive Oncology Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Shariati Hospital, Tehran, Iran.
  • Soares-Lima SC; Digestive Oncology Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Shariati Hospital, Tehran, Iran.
  • Dzamalala C; Digestive Oncology Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Shariati Hospital, Tehran, Iran.
  • Mmbaga BT; Digestive Oncology Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Shariati Hospital, Tehran, Iran.
  • Shibata T; Digestive Oncology Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Shariati Hospital, Tehran, Iran.
  • Menya D; Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, UK.
  • Goldstein AM; Histopathology Department, Hemel Hempstead General Hospital, Hemel Hempstead, UK.
  • Hu N; West Suffolk NHS Foundation Trust, Bury St Edmunds, UK.
  • Malekzadeh R; MRC Cancer Unit, University of Cambridge, Cambridge, UK.
  • Fazel A; Brazilian National Cancer Institute, Rio de Janeiro, Brazil.
  • McCormack V; Brazilian National Cancer Institute, Rio de Janeiro, Brazil.
  • McKay J; University of Malawi, Zomba, Malawi.
  • Perdomo S; Kilimanjaro Clinical Research Institute, Kilimanjaro Christian Medical Centre & Kilimanjaro Christian Medical University College, Moshi, Tanzania.
  • Scelo G; Division of Cancer Genomics, National Cancer Centre Research Institute, Tokyo, Japan.
  • Chanudet E; Moi University, Mombasa, Kenya.
  • Humphreys L; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, MD, USA.
Nat Genet ; 53(11): 1553-1563, 2021 11.
Article em En | MEDLINE | ID: mdl-34663923
ABSTRACT
Esophageal squamous cell carcinoma (ESCC) shows remarkable variation in incidence that is not fully explained by known lifestyle and environmental risk factors. It has been speculated that an unknown exogenous exposure(s) could be responsible. Here we combine the fields of mutational signature analysis with cancer epidemiology to study 552 ESCC genomes from eight countries with varying incidence rates. Mutational profiles were similar across all countries studied. Associations between specific mutational signatures and ESCC risk factors were identified for tobacco, alcohol, opium and germline variants, with modest impacts on mutation burden. We find no evidence of a mutational signature indicative of an exogenous exposure capable of explaining differences in ESCC incidence. Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like (APOBEC)-associated mutational signatures single-base substitution (SBS)2 and SBS13 were present in 88% and 91% of cases, respectively, and accounted for 25% of the mutation burden on average, indicating that APOBEC activation is a crucial step in ESCC tumor development.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas do Esôfago / Mutação Tipo de estudo: Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: America do sul / Asia / Brasil / Europa Idioma: En Revista: Nat Genet Assunto da revista: GENETICA MEDICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas do Esôfago / Mutação Tipo de estudo: Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: America do sul / Asia / Brasil / Europa Idioma: En Revista: Nat Genet Assunto da revista: GENETICA MEDICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido